✦ LIBER ✦

12 Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer

✍ Scribed by P. MACEK; P. STRICKER; M. STEVENS; R. JAGAVKAR; V. CHALASANI; A.M. HAYNES; J. MATTHEWS; P. BRENNER; D. GOLOVSKY; R. KOONER; G. O'NEILL

Book ID: 109052348
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 40 KB
Volume: 97
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2006.06085_12.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in cause-specific mortality

Differences in cause-specific mortality in patients with low-and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy

✍ Jay P. Ciezki; Chandana A. Reddy; Clifford Robinson; Eric A. Klein; Kenneth Ange 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-term outcomes after treatment with

Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features

✍ Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract ## BACKGROUND. This study summarizes long‐term outcomes from treatment of prostate cancer with increased risk of extracapsular cancer extension (ECE) using brachytherapy‐based treatment. ## METHODS. A total of 282 consecutive patients were treated from 1992–1996 by 1 author (M.D.). T

The outcome of radical prostatectomy for

The outcome of radical prostatectomy for patients with prostate cancer and acute urinary retention

✍ Alfonso Fernandez; Stephen E. Pautler 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Toxicity and early treatment outcomes in

Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy

✍ Pirus Ghadjar; Tamara Keller; Cyrill A. Rentsch; Bernhard Isaak; Frank Behrensme 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Hypofractionated external beam radiother

Hypofractionated external beam radiotherapy and single fraction HDR brachytherapy: Improving the results in the treatment of intermediate-risk prostate cancer

✍ Marie Duclos; Fabio Cury; Armen Aprikian; George Shenouda; Sergio Faria; Marc Da 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Toxicity and PSA outcome for patients wi

Toxicity and PSA outcome for patients with intermediate risk prostate cancer after permanent brachytherapy boost and conformal photon or fast neutron radiotherapy

✍ N.A. Kaufman; A.J. Frazier; M. Cher; M. Lutz; F. Ahmad; S. Sircus; C. Maitland; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 56 KB